[{"address1": "455 Mission Bay Boulevard South", "city": "San Francisco", "state": "CA", "zip": "94158", "country": "United States", "phone": "415 482 5300", "fax": "415 339 5300", "website": "https://www.nektar.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally. It develops NKTR-358, a regulatory T (Treg) cell stimulator designed to address the imbalance in the immune system underlying autoimmune disorders and chronic inflammatory conditions; PEG-CSF1, a polyethylene glycol (PEG) modified hematopoietic colony stimulating factor protein that is engineered to selectively modulate resolution processes of inflammation and has applications in a number of therapeutic indications, including acute and chronic inflammation; Tumor necrosis factor (TNF) receptor type II (TNFR2) agonist asset is a bivalent antibody molecule used to selectively stimulate TNFR2 receptor activity, without modulation of the TNFR1 signaling; and NKTR-255, an IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Mr. Howard W. Robin", "age": 71, "title": "CEO, President & Director", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 2166571, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra A. Gardiner", "age": 58, "title": "CFO and Principal Financial & Accounting Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 460850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark A. Wilson J.D.", "age": 52, "title": "Senior VP, Chief Legal Officer & Secretary", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 898297, "exercisedValue": 0, "unexercisedValue": 46583}, {"maxAge": 1, "name": "Dr. Jonathan  Zalevsky Ph.D.", "age": 49, "title": "Senior VP and Chief Research & Development Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 1151200, "exercisedValue": 0, "unexercisedValue": 35833}, {"maxAge": 1, "name": "Mr. Jason  Barnard", "title": "Chief Accounting Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Bacci", "title": "Chief People Officer and Head of Quality & Facilities", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Ruddock", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brian L. Kotzin M.D.", "age": 75, "title": "Interim Chief Medical Officer", "yearBorn": 1949, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 2, "overallRisk": 5, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.nektar.com/", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 26.69, "open": 26.8, "dayLow": 26.3364, "dayHigh": 28.22, "regularMarketPreviousClose": 26.69, "regularMarketOpen": 26.8, "regularMarketDayLow": 26.3364, "regularMarketDayHigh": 28.22, "payoutRatio": 0.0, "beta": 0.964, "forwardPE": -35.4026, "volume": 1203485, "regularMarketVolume": 1203485, "averageVolume": 1925625, "averageVolume10days": 720970, "averageDailyVolume10Day": 720970, "bid": 27.19, "ask": 27.36, "bidSize": 1, "askSize": 1, "marketCap": 518447040, "fiftyTwoWeekLow": 6.45, "fiftyTwoWeekHigh": 37.38, "priceToSalesTrailing12Months": 6.9187155, "fiftyDayAverage": 20.8218, "twoHundredDayAverage": 15.10395, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 519272288, "profitMargins": -1.63172, "floatShares": 17569168, "sharesOutstanding": 19018600, "sharesShort": 1026119, "sharesShortPriorMonth": 1216697, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.059299998, "heldPercentInsiders": 0.00842, "heldPercentInstitutions": 0.47256002, "shortRatio": 0.85, "shortPercentOfFloat": 0.060599998, "impliedSharesOutstanding": 19018600, "bookValue": -1.944, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -122271000, "trailingEps": -8.64, "forwardEps": -0.77, "lastSplitFactor": "1:15", "lastSplitDate": 1749427200, "enterpriseToRevenue": 6.93, "enterpriseToEbitda": -3.786, "52WeekChange": 0.3664161, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 27.26, "targetHighPrice": 120.0, "targetLowPrice": 69.0, "targetMeanPrice": 96.16667, "targetMedianPrice": 99.0, "recommendationMean": 1.875, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 175903008, "totalCashPerShare": 9.249, "ebitda": -137164992, "totalDebt": 176728992, "quickRatio": 2.483, "currentRatio": 2.613, "totalRevenue": 74934000, "revenuePerShare": 5.344, "returnOnAssets": -0.31570998, "returnOnEquity": -4.40799, "grossProfits": 62522000, "freeCashflow": -58484376, "operatingCashflow": -184910000, "revenueGrowth": -0.524, "grossMargins": 0.83435994, "ebitdaMargins": -1.8304801, "operatingMargins": -3.20206, "financialCurrency": "USD", "symbol": "NKTR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -8.64, "epsForward": -0.77, "epsCurrentYear": -10.67933, "priceEpsCurrentYear": -2.5525947, "fiftyDayAverageChange": 6.4382, "fiftyDayAverageChangePercent": 0.3092048, "twoHundredDayAverageChange": 12.156051, "twoHundredDayAverageChangePercent": 0.80482596, "priceToBook": -14.022634, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.9 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1755300351, "regularMarketTime": 1755288000, "exchange": "NCM", "messageBoardId": "finmb_29929", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 767971800000, "shortName": "Nektar Therapeutics", "longName": "Nektar Therapeutics", "regularMarketChangePercent": 2.13563, "regularMarketPrice": 27.26, "postMarketChangePercent": -1.68746, "postMarketPrice": 26.8, "postMarketChange": -0.460001, "regularMarketChange": 0.57, "regularMarketDayRange": "26.3364 - 28.22", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1925625, "fiftyTwoWeekLowChange": 20.810001, "fiftyTwoWeekLowChangePercent": 3.226357, "fiftyTwoWeekRange": "6.45 - 37.38", "fiftyTwoWeekHighChange": -10.120001, "fiftyTwoWeekHighChangePercent": -0.27073303, "fiftyTwoWeekChangePercent": 36.64161, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1754600400, "earningsCallTimestampEnd": 1754600400, "isEarningsDateEstimate": true, "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]